Related Experiment Video
Updated: May 6, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
The applied value of public investments in biomedical research
Danielle Li1, Pierre Azoulay2,3, Bhaven N Sampat3,4
1Harvard Business School, Boston, MA 02163, USA. dli@hbs.edu.
Abstract:
Scientists and policy-makers have long argued that public investments in science have practical applications. Using data on patents linked to U.S. National Institutes of Health (NIH) grants over a 27-year period, we provide a large-scale accounting of linkages between public research investments and subsequent patenting. We find that about 10% of NIH grants generate a patent directly but 30% generate articles that are subsequently cited by patents. Although policy-makers often focus on direct patenting by academic scientists, the bulk of the effect of NIH research on patenting appears to be indirect. We also find no systematic relationship between the "basic" versus "applied" research focus of a grant and its propensity to be cited by a patent.
Related Concept Videos
Ethics in Research
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies: Biowaivers
Drug Products: Biologics, Biosimilars and Interchangeables

